Business
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 Mont-Saint-Guibert, Belgium – March 5 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the fourth quarter and full year of 2025 on Thursday, March 19, 2026. Company management will
About this update from Nyxoah Sa
[{"type":"image","alt":"Nyxoah","displaySize":"","headline":null,"caption":"Nyxoah","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":116,"url":"https://media.zenfs.com/en/globenewswire.com/f090b0134f1a96c88516737ccd77cad1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8mOLPGeisJ61cmygUDQXaw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f090b0134f1a96c88516737ccd77cad1","width":300,"height":116}},"lazy":false},{"type":"text","content":"Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026","length":87,"tagName":"p"},{"type":"text","content":"Mont-Saint-Guibert, Belgium – March 5 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the fourth quarter and full year of 2025 on Thursday, March 19, 2026. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.","length":511,"tagName":"p"},{"type":"text","content":"A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah's Q4 and FY 2025 Earnings Call Webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.","length":273,"tagName":"p"},{"type":"text","content":"If you plan to ask a question, please use the following link: Nyxoah's Q4 and FY 2025 Earnings Call . After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.","length":397,"tagName":"p"},{"type":"text","content":"The archived webcast will be available for replay shortly after the close of the call.","length":86,"tagName":"p"},{"type":"text","content":"About Nyxoah","length":12,"tagName":"p"},{"type":"text","content":"Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio syste...